ARRIVENT BIOPHARMA IN
34.19
08-十一月-24 15:59:57
15 分钟延时
股票
-1.44
-4.04%
今日范围
33.17 - 36.37
ISIN
N/A
来源
NASDAQ
-
ArriVent BioPharma Reports Second Quarter 2024 Financial Results
14 8月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
12 8月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
05 6月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
16 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >